S22-415 A Method for Suppressing Innate Immune Responses to RNA Therapy Stanford researchers have developed a method to suppress immune responses to RNA therapy by chemically treating the RNA with an acylating reagent. Eric Kool Linglan Fang
S22-163 Myc degradation by long non coding RNA for cancer therapeutics Researchers at Stanford University have discovered that the absence of a long non coding RNA (lnc122) predisposed mice to high numbers of hepatocellular carcinomas (HCC), and its replacement decreased the risk of HCC. Mark Kay Hagoon Jang